Protocol of a randomized controlled trial of the fear of recurrence therapy (FORT) intervention for women with breast or gynecological cancer

BACKGROUND: Clinically significant levels of fear of cancer recurrence (FCR) affect up to 49 % of cancer survivors and are more prevalent among women. FCR is associated with psychological distress, lower quality of life, and increased use of medical resources. Despite its prevalence, FCR is poorly a...

Descripción completa

Detalles Bibliográficos
Autores principales: Maheu, Christine, Lebel, Sophie, Courbasson, Christine, Lefebvre, Monique, Singh, Mina, Bernstein, Lori J., Muraca, Linda, Benea, Aronela, Jolicoeur, Lynne, Harris, Cheryl, Ramanakumar, Agnihotram V., Ferguson, Sarah, Sidani, Souraya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845394/
https://www.ncbi.nlm.nih.gov/pubmed/27112319
http://dx.doi.org/10.1186/s12885-016-2326-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845394/
https://www.ncbi.nlm.nih.gov/pubmed/27112319
http://dx.doi.org/10.1186/s12885-016-2326-x

Ejemplares similares